CHINA PHARMA HOLDINGS, INC. Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other
CHINA PHARMA HOLDINGS, INC. (CPHI) had Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other of $8.04 thousand as of 2025-12-31, per its 10-K filed 2026-04-01.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense › Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals
us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther · last filed 2026-04-01
- 2025-12-31: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other $8.04K.
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other $7.11K.
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other $6.75K.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other |
|---|---|
| 2025-12-31 | $8.04K 10-K · filed 2026-04-01 |
| 2024-12-31 | $7.11K 10-K · filed 2026-04-01 |
| 2023-12-31 | $6.75K 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |